Efficacy and Safety of Brivudine in the Treatment of Herpes Zoster
Clinical trial NCT07099157 · RECRUITING
Trial details
- NCT number
- NCT07099157
- Sponsor
- Peking University Third Hospital
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-25
- Primary completion
- 2026-12-31
- Enrollment
- 140
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.